Summary
For Year 2026-27, Global Longlife Hospital and Research reports the following shareholding: Total Promoters at 22.88%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 77.12%. This breakdown provides a quick snapshot of ownership distribution for Global Longlife Hospital and Research in 2026-27.
Global Longlife Hospital and Research FAQs
As of 04-2026, the promoter shareholding in Global Longlife Hospital and Research stands at 22.88% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Global Longlife Hospital and Research is 0% and 0% respectively.
The retail shareholding of the Global Longlife Hospital and Research is 77.12%.
Changes in shareholding patterns of Global Longlife Hospital and Research can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Global Longlife Hospital and Research are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Global Longlife Hospital and Research Associated Pages
- Global Longlife Hospital and Research Share Price
- Global Longlife Hospital and Research Share Price chart
- Global Longlife Hospital and Research Fundamental Analysis
- Global Longlife Hospital and Research Technical Analysis
- Global Longlife Hospital and Research Peer Comparison
- Global Longlife Hospital and Research Share Price History
- Global Longlife Hospital and Research Board of Directors
